Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | NBF-006 |
Synonyms | |
Therapy Description |
NBF-006 is a siRNA-based lipid nanoparticle consisting of an siRNA targeted against glutathione S-transferase P (GSTP), and a biodegradable lipid moiety, which may lead to inhibition of tumor growth (Cancer Res. 2018, 78(13) Supple. pp5917). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
NBF-006 | NBF006|NBF 006 | NBF-006 is a siRNA-based lipid nanoparticle consisting of an siRNA targeted against glutathione S-transferase P (GSTP), and a biodegradable lipid moiety, which may lead to inhibition of tumor growth (Cancer Res. 2018, 78(13) Supple. pp5917). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT03819387 | Phase I | NBF-006 | A Study of NBF-006 in Non-Small Cell Lung, Pancreatic, or Colorectal Cancer | Completed | USA | 0 |